Search for dissertations about: "CLL"
Showing result 11 - 15 of 105 swedish dissertations containing the word CLL.
-
11. Regulation of T-cell proliferation and B-CLL apoptosis by CD6 and FAS/FASL
Abstract : T-cell activation involves the interaction between the T-cell receptor (TCR) and the peptide/MHC complex presented on an antigen-presenting cell. However, this is not sufficient for the full development of T cell responses and co-stimulatory signals from accessory molecules are required. READ MORE
-
12. Characteristics of EBV-infected B cell lines and B-CLL clones which determine their interaction with lymphocytes
Abstract : The results concerning T Iymphocyte mediated recognition of Epstein-Barr virus (EBV) carrying Burkitt Iymphoma (BL) cell lines and EBV-infected chronic Iymphocytic leukemia (CLL) B cells contribute to the understanding of the generally harmless host-EBV interaction and may be extrapolated to the fate of normal B cells after EBV infection. The phenotype of EBV negative BL lines resembles resting B cells. READ MORE
-
13. Restricted antigen recognition in B cell chronic lymphocytic leukemia
Abstract : Chronic lymphocytic leukemia (CLL) cells are considered to be derived from antigen-exposed B cells. To further explore the antigen-driven selection behind the leukemogenesis of CLL, we performed immunoglobulin (Ig) specificity screening of 7 CLL cell lines and 23 primary CLL clones from patient peripheral blood. READ MORE
-
14. Importance of microenvironment and antigen in the regulation of growth and survival of CLL cells
Abstract : Chronic lymphocytic leukemia (CLL) cells rapidly die when put in culture implying that microenvironmental signals delivered by accessory cells confer CLL cells with a growth advantage. Recent findings show that CLL cells are antigen experienced and antigen binding play a critical role in the pathogenesis of the disease. READ MORE
-
15. Targets for immune mediated killing of tumor cells and T cell functions in B-CLL
Abstract : There is a great need for developing and improving treatment alternatives in B-cell chronic lymphocytic leukemia (B-CLL). New therapeutical approaches based on the manipulation of the immune system enable establishment of enhanced control over the malignant clone. READ MORE